Impax Asset Management’s Repligen RGEN Stock Holding History

Impax Asset Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-10,000	Closed	-$129K	–	204
2014 Q1	$129K	Buy	+10,000	New	+$143K	0.01%	194
2013 Q4	–	Sell	-40,000	Closed	-$444K	–	207
2013 Q3	$444K	Sell	40,000 -19,565	-33%	-$195K	0.03%	175
2013 Q2	$491K	Buy	+59,565	New	+$500K	0.03%	173

Other funds holding RGEN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Impax Asset Management's RGEN Position: Q2 2014 in Review

Impax Asset Management sold out of Repligen (RGEN) in Q2 2014, closing a stake of 10,000 shares — an estimated $129K sold.

Impax Asset Management first reported a position in RGEN in Q2 2013 and held it in 3 quarters. The position peaked at $491K in Q2 2013. 163 funds tracked by Wall St. Rank hold RGEN as of Q2 2014.

Impax Asset Management reported no remaining Repligen position as of Q2 2014 after selling out during the quarter.
Impax Asset Management sold 10,000 Repligen shares in Q2 2014, an estimated $129K.
Impax Asset Management first reported a position in Repligen in Q2 2013 and held it in 3 quarters.
Impax Asset Management's Repligen position peaked at $491K in Q2 2013.
163 funds tracked by Wall St. Rank held Repligen as of Q2 2014.

Based on Impax Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.